AQR Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.29M | Buy |
|
|||||
|
2025
Q1 | $1.12M | Buy |
|
|||||
|
2024
Q4 | $1.2M | Buy |
|
|||||
|
2024
Q3 | $568K | Buy |
|
|||||
|
2024
Q2 | $588K | Sell |
|
|||||
|
2024
Q1 | $879K | Sell |
|
|||||
|
2023
Q4 | $1.54M | Buy |
|
|||||
|
2023
Q3 | $1M | Buy |
|
|||||
|
2023
Q2 | $1.11M | Buy |
|
|||||
|
2023
Q1 | $760K | Sell |
|
|||||
|
2022
Q4 | $723K | Buy |
|
|||||
|
2022
Q3 | $653K | Sell |
|
|||||
|
2022
Q2 | $666K | Buy |
|
|||||
|
2022
Q1 | $944K | Buy |
|
|||||
|
2021
Q4 | $646K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $223K | Sell |
|
|||||
|
2020
Q4 | $613K | Sell |
|
|||||
|
2020
Q3 | $876K | Sell |
|
|||||
|
2020
Q2 | $4.84M | Sell |
|
|||||
|
2020
Q1 | $4.73M | Sell |
|
|||||
|
2019
Q4 | $5.75M | Sell |
|
|||||
|
2019
Q3 | $5.48M | Buy |
|
|||||
|
2019
Q2 | $3.52M | Buy |
|
|||||
|
2019
Q1 | $2.79M | Buy |
|
|||||
|
2018
Q4 | $1.21M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $663K | Sell |
|
|||||
|
2017
Q4 | $1.1M | Sell |
|
|||||
|
2017
Q3 | $1.46M | Hold |
|
|||||
|
2017
Q2 | $1.08M | Buy |
|
|||||
|
2017
Q1 | $1.21M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $501K | Sell |
|
|||||
|
2016
Q1 | $900K | Sell |
|
|||||
|
2015
Q4 | $1.35M | Buy |
|
|||||
|
2015
Q3 | $500K | Sell |
|
|||||
|
2015
Q2 | $1.62M | Buy |
|
|||||
|
2015
Q1 | $905K | Sell |
|
|||||
|
2014
Q4 | $1.07M | Sell |
|
|||||
|
2014
Q3 | $925K | Sell |
|
|||||
|
2014
Q2 | $2.25M | Buy |
|
|||||
|
2014
Q1 | $647K | Sell |
|
|||||
|
2013
Q4 | $1.93M | Sell |
|
|||||
|
2013
Q3 | $2.43M | Buy |
|
|||||
|
2013
Q2 | $1.45M | Buy |
|